Virbac - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Virbac. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Virbac. The Group's principal activities are the research, development, manufacture and distribution of veterinary drugs including antibiotics, anti-parasitic drugs, vaccines and dermatological drugs dedicated to animal health care. Their activities are carried out in the following sectors: Pets, Food Producing Animals and other related activities. The Group operates under the brand names Rilexin, Humigel, Novifit, Vet Aquadent, Tenotryl, Megaderm and Anxitan. The Group has operations accross the globe. In 2008, the Group acquired Pharmalett and Schering ranges.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report